MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    A 20-year review of a Movement Disorders Database in Singapore

    YH. Nah, S. Neo, S. Ng, N. Chia, HL. Ng, W. Li, A. Zhan, KY. Tay, Z. Xu, WL. Au, L. Tan (Singapore, Singapore)

    Objective: To conduct a 20-year review of the movement disorders (MD) clinical database in Singapore. Background: MDs contribute to a significant portion of chronic disease…
  • 2023 International Congress

    Digital mobility sub-study in the Parkinson’s Progressive Marker Initiative (PPMI) study.

    A. Mirelman, T. Simuni, C. Tanner, E. Flagg, A. Lorenzo, J. Dimos, C. Coffey, A. Siderowf, K. Marek (Tel Aviv, Israel)

    Objective: To test the feasibility and validity of digital mobility data for enrichment of the prodromal screening and to assess the sensitivity of these measures…
  • 2023 International Congress

    Dance for Parkinson’s disease to improve gait and balance: clinical assessments vs. objective measures.

    HHN. Kalyani, K. Sullivan, G. Moyle, S. Brauer, E. Jeffrey, G. Kerr (Colombo, Sri Lanka)

    Objective: To evaluate how the dance classes based on the Dance for Parkinson’s Disease®(DfPD®) model could improve gait and balance in people with Parkinson’s disease…
  • 2023 International Congress

    ON/OFF Non-Motor Evaluation: A New Way to Evaluate Non-Motor Fluctuations in Parkinson’s Disease

    F. Faggianelli, T. Witjas, JP. Azulay, I. Benatru, C. Hubsch-Bonneaud, M. Anheim, C. Moreau, E. Hainque, S. Drapier, B. Jarraya, C. Laurencin, D. Guehl, L. Hopes, C. Brefel-Courbon, M. Tir, A. Marques, T. Rouaud, D. Maltête, C. Giordana, K. Baumstarck, O. Rascol, JC. Corvol, AS. Rolland, D. Devos, A. Eusebio (Marseille, France)

    Objective: To validate an auto-questionnaire allowing a real time evaluation of the severity of NMF in PD. Background: Non-motor fluctuations (NMF) in Parkinson's disease (PD)…
  • 2023 International Congress

    Impact of Image-Guided Programming (IGP) in Bilateral STN Deep Brain Stimulation on Programming Time and Setting Outcomes

    J. Aldred, T. Zesiewicz, M. Okun, J. Ramirez-Castaneda, L. Verhagen-Mehtman, C. Luca, R. Ramdhani, J. Durphy, Y. Bezchlibnyk, J. Carlson, K. Foote, S. Sani, A. Papanastassiou, J. Jagid, D. Weintraub, J. Pilitsis, B. Reese, L. Chen, R. Jain (Spokane, USA)

    Objective: To determine if an image-guided programming (IGP) tool can enable shorter initial Deep Brain Stimulation (DBS) programming sessions and evaluate continued chronic use of…
  • 2023 International Congress

    Olfactory discrimination ability is associated with subjective lack of social support in female Parkinson’s patients

    T. Blum, L. Consortium, R. Dodel (Essen, Germany)

    Objective: We aimed to explore the relationship between olfactory discrimination ability and subjective social support in a sample of patients with Parkinson’s Disease. We hypothesized…
  • 2023 International Congress

    Drooling is associated with disease severity in Parkinson’s disease

    N. Nishikawa, E. Ikami, H. Takeshige, T. Ogawa, T. Hatano, N. Hattori (Tokyo, Japan)

    Objective: To investigate frequency of PD patients with symptoms of drooling and their clinical characteristics in our Japanese Parkinson's disease (PD) registry data. Background: Drooling…
  • 2023 International Congress

    Healthcare experiences of People with Parkinson’s Disease (PwP) during COVID-19 pandemic

    V. Tomantschger, A. Tautscher-Basnett, C. Hohenwarter (Hermagor, Austria)

    Objective: To investigate how our group of PwP coped with healthcare issues during the pandemic. Background: COVID-19 pandemic led to changes in how healthcare services…
  • 2023 International Congress

    Local field potentials can guide programming of Deep Brain Stimulation in Parkinson’s Disease

    B. Seegmiller, P. Coss (San Antonio, USA)

    Objective: To examine the use of new Deep Brain Stimulation (DBS) local field potential (LFP) sensing technology for selecting the optimal electrode configuration for stimulation during initial…
  • 2023 International Congress

    Functional circuit abnormalities in Levodopa-induced dyskinesia in Parkinson’s disease: A systematic review

    B. Thomsen, M. Vinding, D. Meder, L. Marner, A. Løkkegaard, H. Siebner (Hvidovre, Denmark)

    Objective: Levodopa-induced dyskinesia (LID) in Parkinson’s disease (PD) are involuntary movements caused by long-term treatment with dopaminergic replacement therapy (levodopa). During the cause of PD,…
  • « Previous Page
  • 1
  • …
  • 186
  • 187
  • 188
  • 189
  • 190
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley